We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 2 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 39 actions collected · 1 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 03. 20. | Seaport Global | — | Maintain | Buy → Buy | — | Seaport Global: Buy |
| 2025. 05. 31. | Loop Capital | — | Maintain | Hold → Hold | — | Loop Capital: Hold |
| 2025. 04. 05. | Loop Capital | — | Maintain | Hold → Hold | — | Loop Capital: Hold |
| 2024. 12. 07. | Loop Capital | — | Maintain | Hold → Hold | — | Loop Capital: Hold |
| 2024. 09. 13. | Loop Capital | — | Maintain | Hold → Hold | — | Loop Capital: Hold |
| 2024. 09. 03. | Loop Capital | — | Downgrade | Buy → Hold | — | Loop Capital: Buy → Hold |
| 2024. 03. 21. | Loop Capital | — | Maintain | Buy → Buy | — | Loop Capital: Buy |
| 2024. 03. 20. | Piper Sandler | — | Maintain | Neutral → Neutral | — | Piper Sandler: Neutral |
| 2023. 11. 23. | Piper Sandler | — | Maintain | Neutral → Neutral | — | Piper Sandler: Neutral |
| 2023. 05. 25. | Piper Sandler | — | Downgrade | Overweight → Neutral | — | Piper Sandler: Overweight → Neutral |
| 2023. 02. 21. | Piper Sandler | — | Upgrade | Neutral → Overweight | — | Piper Sandler: Neutral → Overweight |
| 2023. 01. 12. | Piper Sandler | — | Maintain | — → Neutral | — | Piper Sandler: Neutral |
| 2022. 10. 25. | Piper Sandler | — | Initiate coverage | — → Neutral | — | Piper Sandler: Neutral |
| 2022. 06. 24. | Seaport Global | — | Initiate coverage | — → Buy | — | Seaport Global: Buy |
| 2021. 06. 01. | CL King | — | Upgrade | Neutral → Buy | — | CL King: Neutral → Buy |
| 2020. 06. 08. | Susquehanna | — | Downgrade | Neutral → Negative | — | Susquehanna: Neutral → Negative |
| 2020. 04. 07. | Susquehanna | — | Maintain | — → Neutral | — | Susquehanna: Neutral |
| 2020. 02. 18. | Wedbush | — | Maintain | — → Outperform | — | Wedbush: Outperform |
| 2020. 01. 29. | Needham | — | Downgrade | Buy → Hold | — | Needham: Buy → Hold |
| 2019. 07. 22. | Susquehanna | — | Upgrade | Neutral → Positive | — | Susquehanna: Neutral → Positive |
| 2019. 04. 22. | Needham | — | Upgrade | Hold → Buy | — | Needham: Hold → Buy |
| 2019. 04. 10. | Loop Capital | — | Upgrade | Hold → Buy | — | Loop Capital: Hold → Buy |
| 2018. 09. 05. | Macquarie | — | Maintain | Outperform → Outperform | — | Macquarie: Outperform |
| 2018. 08. 29. | Wedbush | — | Maintain | Outperform → Outperform | — | Wedbush: Outperform |
| 2018. 06. 22. | Needham | — | Initiate coverage | — → Hold | — | Needham: Hold |
| 2018. 03. 14. | Buckingham Research | — | Maintain | — → Buy | — | Buckingham Research: Buy |
| 2018. 01. 23. | Susquehanna | — | Downgrade | Positive → Neutral | — | Susquehanna: Positive → Neutral |
| 2017. 05. 30. | Susquehanna | — | Upgrade | Neutral → Positive | — | Susquehanna: Neutral → Positive |
| 2017. 04. 12. | Wedbush | — | Initiate coverage | — → Outperform | — | Wedbush: Outperform |
| 2017. 03. 20. | Susquehanna | — | Downgrade | Positive → Neutral | — | Susquehanna: Positive → Neutral |
| 2017. 03. 03. | Morgan Stanley | — | Upgrade | Equal-Weight → Overweight | — | Morgan Stanley: Equal-Weight → Overweight |
| 2016. 12. 13. | CL King | — | Downgrade | Buy → Neutral | — | CL King: Buy → Neutral |
| 2016. 12. 07. | Susquehanna | — | Upgrade | Neutral → Positive | — | Susquehanna: Neutral → Positive |
| 2016. 11. 24. | Jefferies | — | Maintain | — → Hold | — | Jefferies: Hold |
| 2016. 05. 27. | Jefferies | — | Maintain | — → Hold | — | Jefferies: Hold |
| 2016. 05. 27. | BB&T Capital | — | Downgrade | Buy → Hold | — | BB&T Capital: Buy → Hold |
| 2016. 05. 16. | Susquehanna | — | Maintain | — → Positive | — | Susquehanna: Positive |
| 2016. 01. 27. | BB&T Capital | — | Initiate coverage | — → Hold | — | BB&T Capital: Hold |
| 2015. 08. 29. | Buckingham Research | — | Maintain | — → Neutral | — | Buckingham Research: Neutral |